SOLV
Solventum Corp.
NYSE: SOLV · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$71.65
-1.71% today
Updated 2026-06-05
Market cap
$14.28B
P/E ratio
10.09
P/S ratio
1.73x
EPS (TTM)
$8.17
Dividend yield
—
52W range
$62 – $88
Volume
1.7M
WallStSmart proprietary scores
60
out of 100
Grade: C+
Hold
Investment rating
2.7
Growth
F5.0
Quality
C+7.0
Profitability
B+7.0
Valuation
B+5/9
Piotroski F-Score
Moderate
1.6
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$82.15
+14.65%
12-Month target
$64.67
-9.74%
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy6 Buy6 Hold2 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ ROE 28.82% — strong efficiency
Risks
- Altman Z 1.62 — distress zone
- Negative free cash flow $-273.00M
- Revenue declining -3.00% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $8.13B | $8.20B | $8.25B | $8.32B | $8.26B |
| Net income | $1.34B | $1.35B | $479.00M | $1.56B | $13.00M |
| EPS | — | — | — | — | $8.17 |
| Free cash flow | $1.43B | $1.63B | $805.00M | $-10.00M | $-273.00M |
| Profit margin | 16.52% | 16.42% | 5.80% | 18.69% | 17.30% |
Peer comparison
Smart narrative
Solventum Corp. trades at $71.65. representing a P/E of 10.09x trailing earnings. Our Smart Value Score of 60/100 indicates the stock is good. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 1.62, it sits in the distress. TTM revenue stands at $8.26B. with profit margins at 17.30%.
Frequently asked questions
What is Solventum Corp.'s stock price?
Solventum Corp. (SOLV) trades at $71.65, on a P/E of 10.1x and a P/S of 1.7x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Solventum Corp. overvalued?
Solventum Corp. carries a Smart Value Score of 60/100 (Grade C+), which we rate Hold. That score blends growth, quality, and valuation into one read.
What is the price target of Solventum Corp. (SOLV)?
The 12-month analyst consensus target is $82.15, about 14.7% above the current $71.65. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is Solventum Corp.'s revenue?
Solventum Corp.'s trailing twelve-month revenue is $8.26B. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Solventum Corp.'s Altman Z-Score is 1.62, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL INSTRUMENTS & SUPPLIES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio1.73x
ROE28.82%
Beta0.75
50D MA$71.04
200D MA$74.16
Shares out0.17B
Float0.15B
Short ratio—
Avg volume1.7M
Performance
1 week+0.00%
1 month+9.09%
3 months+20.66%
YTD+2.23%
1 year—
3 years—
5 years—